🇺🇸 FDA
Patent

US 10604501

Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting

granted A61KA61K47/50A61K47/545

Quick answer

US patent 10604501 (Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K47/50, A61K47/545, A61K49/0032, A61K49/0052